Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07291102 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a trial to compare neurocognitive outcomes in the intent-to-treat population 2.5 years after diagnosis between patients with newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non-MYC amplified MF randomized to the interventional arms A ("Head Start 4") or B (HIT-SKK).
Trial Details
NCT Number NCT07291102
Lead Sponsor Nationwide Children's Hospital
Collaborators: German Society of Paediatric Oncology and Hematology (GPOH gGmbH), Children's of Alabama
Conditions
(from sponsor)		 Medulloblastoma
Related terms Medulloblastoma
Enrollment 96 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov